Home › NDC Lookup › RxCUI directory › RxCUI 1048123

Zinc pyrithione 20 MG/ML Medicated Liquid Soap — RxCUI 1048123

RxNorm drug concept · Semantic clinical drug
RxCUI 1048123 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1048123
Official nameZinc pyrithione 20 MG/ML Medicated Liquid Soap
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aszinc pyrithione 2 % Medicated Liquid Soap
FDA products mapped2
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Zinc pyrithione 20 MG/ML Medicated Liquid Soap Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zinc pyrithione 20 MG/ML Medicated Liquid Soap RxCUI 1048123

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zinc pyrithione 39952
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zinc pyrithione Medicated Liquid Soap 1048122
    • Zinc pyrithione Soap Product 1294908
    • Medicated Liquid Soap 316955
    • Soap Product 1294721
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Zinc pyrithione 20 MG/ML 333233

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zinc pyrithione 20 MG/ML SCDC · 333233
  • Zinc pyrithione Medicated Liquid Soap SCDF · 1048122
  • Zinc pyrithione Soap Product SCDG · 1294908

📦 FDA Products & Package NDCs

2 products · 10 package NDCs
10 package NDCs map to RxCUI 1048123 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71819-0007-04 118 mL in 1 BOTTLE, PLASTIC (71819-007-04) Zinc Therapy D3 Development, Inc. 2018-01-23
71819-0007-10 296 mL in 1 BOTTLE, PLASTIC (71819-007-10) Zinc Therapy D3 Development, Inc. 2019-07-02
71819-0007-12 355 mL in 1 BOTTLE, PLASTIC (71819-007-12) Zinc Therapy D3 Development, Inc. 2018-01-23
71819-0007-64 1893 mL in 1 BOTTLE, PLASTIC (71819-007-64) Zinc Therapy D3 Development, Inc. 2018-01-23
71819-0007-99 3785 mL in 1 BOTTLE, PLASTIC (71819-007-99) Zinc Therapy D3 Development, Inc. 2018-01-23
71819-0016-04 118 mL in 1 BOTTLE, PLASTIC (71819-016-04) Dermaharmony Zinc Therapy D3 Development, Inc. 2021-09-05
71819-0016-10 296 mL in 1 BOTTLE, PLASTIC (71819-016-10) Dermaharmony Zinc Therapy D3 Development, Inc. 2021-09-05
71819-0016-12 355 mL in 1 BOTTLE, PLASTIC (71819-016-12) Dermaharmony Zinc Therapy D3 Development, Inc. 2021-09-05
71819-0016-64 1893 mL in 1 BOTTLE, PLASTIC (71819-016-64) Dermaharmony Zinc Therapy D3 Development, Inc. 2021-09-05
71819-0016-99 3785 mL in 1 BOTTLE, PLASTIC (71819-016-99) Dermaharmony Zinc Therapy D3 Development, Inc. 2021-09-05
Observed labelers: D3 Development, Inc. (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.